These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14463817)

  • 21. Trifluoperazine ('stelazine')--a review of recent work.
    CULLEN W
    J R Nav Med Serv; 1959; 45():136-9. PubMed ID: 13813242
    [No Abstract]   [Full Text] [Related]  

  • 22. The neuropharmacology of trifluoperazine: a potent psychotherapeutic agent.
    TEDESCHI DH; TEDESCHI RE; COOK L; MATTIS PA; FELLOWS EJ
    Arch Int Pharmacodyn Ther; 1959 Oct; 122():129-43. PubMed ID: 13837256
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of the interpersonal field on the emergence and recognition of psychopharmacological changes.
    WIEDORN WS; DAVIS FH
    Psychiatr Q; 1960 Jul; 34():488-94. PubMed ID: 13785075
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of stelazine and parnate in chronic, withdrawn patients.
    VOGT AH
    Am J Psychiatry; 1961 Sep; 118():256-7. PubMed ID: 13781857
    [No Abstract]   [Full Text] [Related]  

  • 25. A clinical trial in sea-sickness with trifluoperazine ('stelazine').
    TURNBULL TA
    J R Nav Med Serv; 1959; 45():132-5. PubMed ID: 13839926
    [No Abstract]   [Full Text] [Related]  

  • 26. Intravenous trifluoperazine (Stelazine) as a postoperative anti-emetic.
    BLATCHFORD E; ROBERTS H
    Can Anaesth Soc J; 1962 Jul; 9():347-52. PubMed ID: 13869887
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical investigation of trifluoperazine (stelazine) in open psychiatric settings.
    SARWER-FONER GJ; KORANYI EK; MACKAY J; GRAUER H
    Can Med Assoc J; 1959 Nov; 81(9):717-23. PubMed ID: 14441852
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of trifluoperazine in chronic Negro schizophrenics.
    SEXTON MC
    Am J Psychiatry; 1959 Mar; 115(9):821-2. PubMed ID: 13627269
    [No Abstract]   [Full Text] [Related]  

  • 29. Alterations of evoked potentials in psychotic patients under the influence of chlorpromazine and trifluoperazine.
    Kopylova TV
    Electroencephalogr Clin Neurophysiol; 1969 Oct; 27(4):449. PubMed ID: 4186762
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical trial of stelazine therapy in schizophrenia refractory to alternative treatments].
    WINNIK HZ; ASSAEL M; GABBAI F
    Dapim Refuiim; 1962 Apr; 21():161-8. PubMed ID: 14007552
    [No Abstract]   [Full Text] [Related]  

  • 31. Qualitative and quantitative EEG changes of intramuscular thiothixene and trifluoperazine in chronic schizophrenia.
    Akpinar S; Itil TM; Holden JM; Hsu W
    Dis Nerv Syst; 1972 Jan; 33(1):40-5. PubMed ID: 5059688
    [No Abstract]   [Full Text] [Related]  

  • 32. [TRIAL SYSTEMATIZATION OF NEUROLEPTIC COMBINATIONS].
    LAMBERT PA
    Encephale; 1964; 53():SUPPL:262-75. PubMed ID: 14161540
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of phenothiazines on reaction time in schizophrenics.
    Held JM; Cromwell RL; Frank ET; Fann WE
    J Psychiatr Res; 1970 Feb; 7(3):209-13. PubMed ID: 5440861
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pharmacology of ethmosine].
    Kaverina NV; Senova ZP; Mitrofanov VS; Runova MF
    Farmakol Toksikol; 1972; 35(2):182-5. PubMed ID: 4401791
    [No Abstract]   [Full Text] [Related]  

  • 35. [CHANGES IN THE CORTEX-SUBCORTEX RELATIONSHIP UNDER THE INFLUENCE OF AMINAZIN].
    KOSTANDOV EA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1964; 14():397-405. PubMed ID: 14260466
    [No Abstract]   [Full Text] [Related]  

  • 36. [STELAZINE THERAPY OF PROLONGED SCHIZOPHRENIA].
    KUTSENOK BM; ZOLOTNITSKII RI; RUBCHINSKAIA RM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1964; 64():1386-90. PubMed ID: 14248183
    [No Abstract]   [Full Text] [Related]  

  • 37. [Electroencephalographic study of a group of schizophrenics in the course of improvement induced in disorders of higher nervous function by chlorpromazine therapy].
    BIZZI B
    Rass Studi Psichiatr; 1959; 48():610-20. PubMed ID: 13801070
    [No Abstract]   [Full Text] [Related]  

  • 38. THE BLOOD-CEREBROSPINAL FLUID BARRIER IN CHRONIC SCHIZOPHRENIA AND AFTER TRIFLUOPERAZINE (STELAZINE) TREATMENT.
    GUERRANT J; BECKER RA; ANDERSON WW; AIRD RB
    J Nerv Ment Dis; 1964 Sep; 139():222-31. PubMed ID: 14212174
    [No Abstract]   [Full Text] [Related]  

  • 39. [Stelazine therapy of patients with the paranoid form of schizophrenia].
    GALENKO VE; KEL'MISHKEIT EG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1963; 63():269-75. PubMed ID: 13960318
    [No Abstract]   [Full Text] [Related]  

  • 40. Consideration of use of phenothiazines in particular trifluorperazine for epidermal growth factor receptor associated cancers.
    Kast RE; Altschuler EL
    Med Hypotheses; 2007; 69(5):1074-5. PubMed ID: 17448610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.